Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Shenzhen Hepalink Pharmaceutical Group. (9989.HK) Q3 2024 Earnings
9989.HK
30
Aug
Confirmed
Q2 2023
Q3 2023
Q2 2024
Q3 2024
0
0.13
0.25
0.38
Details
Expected EPS
0.33256890767999997
Actual EPS
0.3754810248
Surprise EPS
0.04
Surprise Percent
+12.9%
Description
Shenzhen Hepalink Pharmaceutical Group. (9989.HK) has reported earnings of 0.3754810248 per share for Q3 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login